Skip to main content
Aarti Industries Ltd logo

Aarti Industries Ltd — Investor Relations & Filings

Ticker · AARTIIND ISIN · INE769A01020 LEI · 335800JBE5SD89NHB831 BSE.NS Manufacturing
Filings indexed 1,191 across all filing types
Latest filing 2023-02-03 Regulatory Filings
Country IN India
Listing BSE.NS AARTIIND

About Aarti Industries Ltd

https://www.aarti-industries.com/

Aarti Industries Ltd is a global manufacturer of specialty chemicals and pharmaceuticals, specializing in benzene-based derivatives. The company utilizes complex chemical processes such as chlorination, nitration, hydrogenation, and ammonolysis to produce a wide range of intermediates. Key products include nitrochlorobenzenes, dichlorobenzenes, phenylenediamines, and various sulfuric acid derivatives. These chemicals serve as critical inputs for the agrochemical, pharmaceutical, polymer, additive, surfactant, and pigment sectors. With a strong emphasis on research and development, the company operates integrated manufacturing complexes designed for process efficiency and environmental compliance. Its technical expertise allows for the production of high-purity chemicals used in crop protection, life-saving medicines, and advanced materials for industrial applications.

Recent filings

Filing Released Lang Actions
Dividend
Regulatory Filings
2023-02-03 English
Financial Result Updates
Regulatory Filings
2023-02-03 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a notification letter addressed to stock exchanges (BSE and NSE) about a scheduled quarterly earnings call for Aarti Industries Limited. It references Regulation 30(6) of SEBI (LODR) Regulations, 2015, which pertains to disclosure of material events. The document announces the date and time of the earnings call to discuss Q3 FY23 results, including details for dial-in and management participants. It does not contain actual financial results or detailed financial statements but is an announcement of an upcoming event related to earnings results. Therefore, it is not the earnings release itself nor a full quarterly report but an announcement about the earnings call. According to the filing definitions and rules, such a document fits best under Call Transcript (CT) category as it relates to the earnings call event. However, since this is only an invitation/announcement of the call and not the transcript, the closest appropriate category is Regulatory Filings (RNS) as a general regulatory announcement about the earnings call schedule. Confidence is high given the clear nature of the document as an announcement of the earnings call schedule without financial data or transcript content.
2023-01-25 English
Board Meeting — Financial Results/Dividend
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to stock exchanges informing about an upcoming Board Meeting scheduled for February 3, 2023. The agenda includes consideration and approval of audited financial results for the quarter and nine months ended December 31, 2022, and declaration of interim dividend. The document references Regulation 29 of SEBI (LODR) Regulations, 2015, which pertains to disclosure of events or information by listed entities. The document is brief (1355 characters) and serves as an announcement of a future event (board meeting) and not the actual financial results or dividend declaration. It does not contain any financial data or detailed report. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement and does not fit other specific categories like Interim Report or Dividend Notice. It is not a report publication announcement because it does not mention publication or attachment of any report.
2023-01-23 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the issuance of a Letter of Confirmation in lieu of a Duplicate Share Certificate, pursuant to a specific regulation (Regulation 39(3) of SEBI (LODR) Regulations, 2015). It lists shareholder details and share certificate numbers. The content is a regulatory compliance announcement related to share certificates, not a financial report, earnings release, or management discussion. The document length is short (1607 characters) and it serves as an official notification to the exchanges. This fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-01-11 English
Updates
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, addressed to stock exchanges. It is a compliance certificate related to shareholding or depository participant regulations for the quarter ended December 31, 2022. The document is short (1132 characters) and does not contain financial statements or detailed financial data. It is a regulatory compliance filing rather than a financial report or announcement of voting results, management changes, or capital changes. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents.
2023-01-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.